Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3

被引:76
|
作者
Huang, YH
Galijatovic, A
Nguyen, N
Geske, D
Beaton, D
Green, J
Green, M
Peters, WH
Tukey, RH [1 ]
机构
[1] Univ Calif San Diego, Ctr Canc, Dept Chem & Biochem & Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA
[2] Univ Nijmegen St Radboud Hosp, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
来源
PHARMACOGENETICS | 2002年 / 12卷 / 04期
关键词
polymorphism; glucuronidation; drug metabolism; pharmacogenomics;
D O I
10.1097/00008571-200206000-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
UDP-glucuronosyltransferase (UGT) 1A8 is part of the UGT1 locus and is expressed exclusively in extrahepatic tissues. Analysis of UGT1A8 exon 1 sequence has identified four genotypes from a population of 69 individuals. While there are four alleles, one of the single base pair changes leads to a silent mutation at T-255, while the other mutations lead to amino acid substitutions at positions 173 and 277, creating three allelic variants. UGTlA8*1 (A(173)C(277)), UGTlA8*1a (T-255 A>G), UGT1A8*2 (G(173)C(277)) and UGT1A8*3 (A(173)Y(277)). The allelic frequencies of UGT1A8*1, UGT1A8* 1a, UGT1A8*2 and UGT1A8*3 are 0.551, 0.282, 0.145 and 0.022, respectively. To examine the properties of the UGT1A8 proteins, UGT1A8*1 and UGT1A8*2 were cloned from a human colon cDNA library and UGT1A8*3 generated by mutagenesis using UGT1A8*1 as template. The cDNAs were expressed in HK293 cells to examine catalytic function as well as abundance as observed by analysis of UGT1A8-GFP (green fluorescent protein) expression. The single amino acid change that identifies UGT1A8* 1 (A(173)) and UGT1A8*2 (G(173)) has little impact on function, while the UGT1A8*3 (Y-277) is a conserved amino acid alteration represented by a dramatic reduction in catalytic activity. Protein abundance, as determined by Western blot analysis following transient transfection, is not altered. In addition, functional UGT1A8-GFP variants displayed staining in the cytoplasmic region, indicating that each protein is expressed in similar cellular compartments. Together, these data suggest that the null UGT1A8*3 results from structural changes and not a lack of protein expression. Allelic variation leading to singular codon changes could potentially alter drug metabolism in extrahepatic tissues.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 50 条
  • [31] The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
    Zhao, Feng
    Wang, Xi
    Wang, Yan
    Zhang, Jingbo
    Lai, Ran
    Zhang, Bei
    Zhou, Xueyan
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (03): : 403 - 412
  • [32] ASSOCIATION OF GENETIC POLYMORPHISMS OF UGT1A8, UGT1A9,SLCO1B3 AND ABCC2/ABCG2 ON PHARMACOKINETICS OF MYCOPHENOLIC ACID IN CHINESE
    Geng, F.
    Jiao, Z.
    Dao, Y.
    Qiu, X.
    Shi, X.
    Li, Z.
    Zhong, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S53 - S53
  • [33] The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers
    Levesque, E.
    Delage, R.
    Benoit-Biancamano, M-O
    Caron, P.
    Bernard, O.
    Couture, F.
    Guillemette, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 392 - 400
  • [34] UDP-Glucuronosyltransferases:: Gene structures of UGT1 and UGT2 families
    Owens, IS
    Basu, NK
    Banerjee, R
    PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 : 1 - 22
  • [35] Tramadol-related fatalities: Metabolic ratios & SNPs/INDELs belonging to UGT1A8, UGT2B7, ABCC2, and SLC22A1
    Aly, Sanaa M.
    Sabaouni, Naoual
    Hennart, Benjamin
    Gaulier, Jean-michel
    Allorge, Delphine
    FORENSIC SCIENCE INTERNATIONAL-GENETICS, 2025, 76
  • [36] Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model
    Mei, Shenghui
    Feng, Weixing
    Zhu, Leting
    Li, Xingang
    Yu, Yazhen
    Yang, Weili
    Gao, Baoqin
    Wu, Xiaojuan
    Fang, Fang
    Zhao, Zhigang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (08) : 1029 - 1036
  • [37] Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model
    Shenghui Mei
    Weixing Feng
    Leting Zhu
    Xingang Li
    Yazhen Yu
    Weili Yang
    Baoqin Gao
    Xiaojuan Wu
    Fang Fang
    Zhigang Zhao
    European Journal of Clinical Pharmacology, 2018, 74 : 1029 - 1036
  • [38] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [39] Effect of polyethylene glycol 400 on the pharmacokinetics and tissue distribution of baicalin by intravenous injection based on the enzyme activity of UGT1A8/1A9
    Shang, Le-Yuan
    Zhou, Ming-Hao
    Cao, Si-Yuan
    Zhang, Min
    Wang, Peng-Jiao
    Zhang, Shuo
    Meng, Xiao-Xia
    Yang, Qi-Mei
    Gao, Xiu-Li
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 180
  • [40] The Influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Silodosin in Healthy Chinese Volunteers
    Wang, Zining
    Xiang, Qian
    Cui, Yimin
    Zhao, Xia
    Zhou, Ying
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (03) : 239 - 243